Cyclacel Pharmaceuticals ... (CYCCP)
NASDAQ: CYCCP
· Real-Time Price · USD
5.50
0.08 (1.51%)
At close: Aug 15, 2025, 2:47 PM
5.97
8.55%
After-hours: Aug 15, 2025, 07:30 PM EDT
Cyclacel Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | -35K | 10K | 4K | 29K | 31K | 16K | 373K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 4K | 1K | 2K | 2K | 8K | 7K | 372.63K | n/a | 8K | 7K | 8K | 9K | 7K | 10K | 17K | 9K |
Gross Profit | n/a | n/a | -39K | 10K | 4K | 29K | 31K | 9K | 373.00 | n/a | -8K | -7K | -8K | -4.94M | -7K | -10K | -17K | -9K |
Operating Income | n/a | -5.04M | -1.83M | -2.18M | -3.64M | -4.36M | -5.36M | -6.84M | -5.93M | -7.32M | -8.85M | -6.47M | -5.79M | -6.56M | -6.53M | -6M | -6.1M | -4.3M |
Interest Income | n/a | 6K | 30K | 8K | -28K | 2K | 23K | 50K | 77K | 116K | 122K | 67K | 17K | 4K | 4K | 4K | 4K | 4K |
Pretax Income | -1.32K | -81K | -1.86M | -2.17M | -3.67M | -4.3M | -5.69M | -6.7M | -6.03M | -7.12M | -9M | -6.11M | -5.56M | -5.25M | -6.49M | -5.99M | -6.09M | -4.17M |
Net Income | -1.32K | -81K | -3.05M | -1.96M | -3.26M | -2.95M | -5.27M | -6.03M | -5.45M | -5.8M | -7.42M | -5.1M | -4.58M | -4.11M | -5.29M | -4.99M | -5.13M | -3.48M |
Selling & General & Admin | 1.25K | 4.21M | 948K | 1.24M | 1.63M | 1.58M | 1.87M | 1.63M | 1.57M | 1.65M | 2.14M | 2.05M | 1.58M | 1.6M | 1.94M | 1.78M | 2M | 1.74M |
Research & Development | 68.00 | 822K | 879K | 950K | 2.02M | 2.8M | 3.52M | 5.24M | 4.73M | 5.67M | 6.7M | 4.41M | 4.21M | 4.95M | 4.59M | 4.22M | 4.1M | 2.57M |
Other Expenses | n/a | n/a | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.32K | 5.04M | 1.83M | 2.19M | 3.65M | 4.38M | 5.39M | 6.86M | 6.3M | 7.32M | 8.85M | 6.47M | 5.79M | 6.56M | 6.53M | 6M | 6.1M | 4.3M |
Interest Expense | n/a | n/a | n/a | n/a | 28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 5.04M | 1.83M | 2.19M | 3.65M | 4.38M | 5.39M | 6.86M | 6.3M | 7.32M | 8.85M | 6.47M | 5.79M | 6.56M | 6.53M | 6M | 6.1M | 4.3M |
Income Tax Expense | n/a | n/a | 1.19M | -210K | -412K | -4.28M | -422K | -668K | -586K | -1.32M | -1.58M | -1.01M | -984K | -1.14M | -1.2M | -998K | -964K | -687K |
Shares Outstanding (Basic) | n/a | 12.96K | 8.66M | 2.02M | 1.69M | 1.22M | 854.02K | 842.85K | 836.82K | 836.28K | 835.93K | 820.97K | 675.74K | 666.2K | 656.02K | 624.52K | 615.6K | 473.26K |
Shares Outstanding (Diluted) | n/a | 12.96K | 8.66M | 2.02M | 1.69M | 1.22M | 854.02K | 842.85K | 836.82K | 836.28K | 835.93K | 820.97K | 675.74K | 666.2K | 656.02K | 624.52K | 615.6K | 473.26K |
EPS (Basic) | -0.98 | -6.25 | -0.35 | -0.97 | -1.93 | -2.43 | -6.23 | -7.19 | -6.54 | -6.97 | -8.92 | -6.24 | -6.8 | -6.2 | -8.12 | -8.03 | -8.38 | -7.39 |
EPS (Diluted) | -0.98 | -6.25 | -0.35 | -0.97 | -1.93 | -2.43 | -6.23 | -7.19 | -6.54 | -6.97 | -8.92 | -6.24 | -6.8 | -6.2 | -8.12 | -8.03 | -8.38 | -7.39 |
EBITDA | n/a | -5.04M | -1.89M | -2.18M | -3.64M | -4.35M | -5.35M | -6.84M | -5.92M | -7.31M | -8.84M | -6.46M | -5.78M | -6.55M | -6.48M | -5.99M | -6.08M | -4.3M |
EBIT | n/a | -5.04M | -1.89M | -2.18M | -3.64M | -4.36M | -5.36M | -6.84M | -5.93M | -7.32M | -8.85M | -6.47M | -5.79M | -6.56M | -6.49M | -6M | -6.1M | -4.3M |
Depreciation & Amortization | n/a | 1.5K | 1K | 1K | 2K | 2K | 8K | 7K | 8K | 8K | 8K | 7K | 8K | 9K | 7K | 10K | 17K | 9K |